NCT00870051

Endurant Stent Graft Natural Selection Global Postmarket Registry

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 1,266 (actual)
• Sponsor: Medtronic Cardiovascular · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of ENGAGE is to prospectively collect global 'real world' data on the Endurant Stent Graft System from AAA subjects.

Detailed description

The Endurant Stent Graft Natural Selection Global Post-market Registry, ENGAGE is initiated to expand the clinical knowledge base by including 'real world' subjects, applying a minimal amount of subject selection criteria. This subject group may better represent the subject profile treated in actual clinical practice without selecting sub-groups of particular low/high risk or excluding certain diseases. ENGAGE aims at following and documenting the subject selections, diagnostic tools used and treatment interventions chosen by the vascular surgeon or interventional radiologist. ENGAGE will not impose CIP required study procedures affecting clinical practice.

Conditions

• Aortic Aneurysm, Abdominal

Interventions

Type	Name	Description
DEVICE	Endurant Stent Graft	Endurant Stent Graft implantation

Timeline

• Start date: 2009-04-08
• Primary completion: 2021-09-23
• Completion: 2021-09-23
• First posted: 2009-03-26
• Last updated: 2022-02-09

Locations

80 sites across 30 countries: Argentina, Australia, Austria, Belgium, Canada, China, Colombia, Czechia, France, Germany, Greece, Hong Kong, Israel, Italy, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Slovakia, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey (Türkiye), United Kingdom, Uruguay